Accuray Incorporated's CEO to Speak at Leerink Swan Global Healthcare Conference
* Reuters is not responsible for the content in this press release.
For best results when printing this announcement, please click on the link below: http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130211:nPnSF57484 SUNNYVALE, Calif., Feb. 11, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its president and chief executive officer, Joshua H. Levine, is scheduled to present at the Leerink Swan Global Healthcare Conference in New York on Thursday, February 14, 2013 at 9:20 a.m. EST/6:20 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days. About Accuray Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com. SOURCE Accuray Incorporated Investors, Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458, email@example.com; or Media, Rebecca Phillips, Public Relations Manager, +1-408-716-4773, firstname.lastname@example.org
- Target stores' customers hit by major credit card attack
- UPDATE 3-Saab wins Brazil jet deal after NSA spying sours Boeing bid
- Facebook, Zuckerberg, banks must face IPO lawsuit: judge
- U.S. prosecutor defends treatment of Indian diplomat |
- Fed cuts bond buying in first step away from historic stimulus |